Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APPswe/PS1dE9 transgenic mice: Effect of long-term treatment with paroxetine

Neurobiol Dis. 2017 Aug:104:50-60. doi: 10.1016/j.nbd.2017.04.021. Epub 2017 Apr 28.

Abstract

Altered neurogenesis may influence hippocampal functions such as learning and memory in Alzheimer's disease. Selective serotonin reuptake inhibitors enhance neurogenesis and have been reported to reduce cerebral amyloidosis in both humans and transgenic mice. We have used stereology to assess the longitudinal changes in the number of doublecortin-expressing neuroblasts and number of granular neurons in the dentate gyrus of APPswe/PS1dE9 transgenic mice. Furthermore, we investigated the effect of long-term paroxetine treatment on the number of neuroblasts and granular neurons, hippocampal amyloidosis, and spontaneous alternation behaviour, a measure of spatial working memory, in transgenic mice. We observed no difference in granular neurons between transgenic and wild type mice up till 18months of age, and no differences with age in wild type mice. The number of neuroblasts and the performance in the spontaneous alternation task was reduced in aged transgenic mice. Paroxetine treatment from 9 to 18months of age reduced hippocampal amyloidosis without affecting the number of neuroblasts or granular neurons. These findings suggest that the amyloidosis affects the differentiation of neuroblasts and spatial working memory, independent of changes in total granular neurons. Furthermore, while long-term paroxetine treatment may be able to reduce hippocampal amyloidosis, it appears to have no effect on total number of granular neurons or spatial working memory.

Keywords: APP/PS1 mice; Amyloid plaque load; Granule cells; Hippocampus; Neurogenesis; Paroxetine; SSRI; Spontaneous alternation behaviour.

MeSH terms

  • Aging / genetics
  • Aging / pathology*
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Protein Precursor / genetics
  • Animals
  • Bromodeoxyuridine / metabolism
  • Cytochrome P-450 CYP2D6 Inhibitors / therapeutic use
  • Dentate Gyrus / drug effects
  • Dentate Gyrus / pathology*
  • Disease Models, Animal
  • Doublecortin Domain Proteins
  • Exploratory Behavior / drug effects
  • Maze Learning / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microtubule-Associated Proteins / metabolism
  • Mutation / genetics
  • Neural Stem Cells / drug effects
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / pathology*
  • Neurogenesis / drug effects
  • Neurogenesis / physiology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology*
  • Neuropeptides / metabolism
  • Paroxetine / therapeutic use
  • Presenilin-1 / genetics

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Cytochrome P-450 CYP2D6 Inhibitors
  • Doublecortin Domain Proteins
  • Microtubule-Associated Proteins
  • Neuropeptides
  • Presenilin-1
  • Paroxetine
  • Bromodeoxyuridine